Policy Studies Competition Policy, Disintermediation, Federal Government Affairs The Devil Is in the Details: Reviewing OTC Birth Control Efforts in Congress and Their Potential Impacts Courtney Joslin, Sophia Heimowitz March 23, 2023
In the News Competition Policy, Disintermediation, Federal Government Affairs Rep. Nancy Mace Introduces Bill to Increase Over-The-Counter Contraceptive Options for Women Anthony Lamorena March 9, 2023 Congresswoman Nancy Mace
Explainers Competition Policy, Disintermediation, State Policy, Western Pharmacy Access to Birth Control: Lessons From New Mexico Courtney Joslin, Sophia Heimowitz March 6, 2023
Explainers Competition Policy, Disintermediation, Northeast, State Policy Support SB171:Pharmacist-Prescribed Birth Control Robert Melvin March 3, 2023
Testimony Competition Policy, Disintermediation R Street Testimony in Support of CT SB 171 “An Act Allowing Pharmacists to Prescribe Birth Control Medication.” Robert Melvin March 3, 2023
R Sheets Competition Policy, Disintermediation, Northeast, State Policy Birth Control Access in New Jersey Courtney Joslin Dec 15, 2022
Analysis Competition Policy, Disintermediation, Midwest, State Policy When it comes to birth control access, Gov. Whitmer and her colleagues have work to do Courtney Joslin, Sophia Heimowitz Dec 6, 2022
Op-Eds Competition Policy, Disintermediation A Free Market Solution for Women’s Healthcare Marc Hyden July 25, 2022 Newnan Times-Herald
Real Solutions Competition Policy, Disintermediation Here’s what the first-ever over-the-counter birth control pill (in the United States) could mean for contraceptive access and choice Courtney Joslin July 14, 2022
In the News Competition Policy, Disintermediation A Pro-Choicer and a Pro-Lifer Do Lunch Courtney Joslin July 5, 2022 The Bulwark
